Filter posts

FDA Approval of GE Salmon Paves Way for Sustainable Food Innovations

Earlier this week, the U.S. Food & Drug Administration (FDA) finally approved the sale of …

#BIO2019 Education Programming Taking Shape

With the BIO International Convention (BIO 2019) only three months away, the finishing touches are …

Two New Infographics Illustrate the Success of the Orphan Drug Act

In recognition of Rare Disease Day, BIO’s Jim Greenwood shared commentary on LinkedIn celebrating the …

National Pork Producers Council President: Don’t Strangle Promising Technology With Red Tape

In a recent op-ed, National Pork Producers Council President Jim Heimerl highlighted the benefits of gene …

New Study Suggests Those Extremely Opposed to GMOs Know the Least About GMOs

Genetically modified organisms (GMOs) can provide real solutions to some of our most pressing challenges. …

Opportunities for Patient and Health Advocates

Last week, the seventh annual Patient and Health Advocacy Summit brought  hundreds of patient advocates, …

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Within the past year, the FDA has launched a provider pre-certification program as a pilot …

Drug Importation: Dangerous for Patients, Consumers, and American Communities

Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a …

The Importance of Accurate Food Labels

Food labels are a hot topic right now. The U.S. Food and Drug Administration (FDA) …

FDA Protects Patients While Promoting Innovation

Today, 83 percent of children with cancer survive, compared to just 58 percent in the …